{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:05:43Z","timestamp":1792623943711,"version":"4.5.0"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,22]]},"DOI":"10.7759\/cureus.90748","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T14:29:06Z","timestamp":1755872946000},"source":"Crossref","is-referenced-by-count":2,"title":["Effect of Perioperative Dexmedetomidine in Cardiac Surgery: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Zhengmin","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuhai","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bohringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2021.11.003","article-title":"Transcatheter aortic valve replacement (TAVR): recent updates","volume":"69","author":"Avvedimento M","year":"2021","unstructured":"Avvedimento M, Tang GH. Transcatheter aortic valve replacement (TAVR): recent updates. Prog Cardiovasc Dis. 2021, 69:73-83. 10.1016\/j.pcad.2021.11.003","journal-title":"Prog Cardiovasc Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2024.01.003","article-title":"Shaping the anesthetic approach to tricvalve implantation: insights from a case series","volume":"38","author":"Pieri M","year":"2024","unstructured":"Pieri M, Dormio S, Morosato M, Belletti A, Silvestri D, Montorfano M, Monaco F. Shaping the anesthetic approach to tricvalve implantation: insights from a case series. J Cardiothorac Vasc Anesth. 2024, 38:911-7. 10.1053\/j.jvca.2024.01.003","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2016.11.013","article-title":"TAVR-related complications: why did we forget the design of a normal aortic valve?","volume":"10","author":"Sengupta PP","year":"2017","unstructured":"Sengupta PP, Narula J. TAVR-related complications: why did we forget the design of a normal aortic valve?. JACC Cardiovasc Imaging. 2017, 10:100-3. 10.1016\/j.jcmg.2016.11.013","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cnc.2019.05.011","article-title":"End-of-life care in cardiothoracic surgery","volume":"31","author":"Birriel B","year":"2019","unstructured":"Birriel B, D'Angelo K. End-of-life care in cardiothoracic surgery. Crit Care Nurs Clin North Am. 2019, 31:453-60. 10.1016\/j.cnc.2019.05.011","journal-title":"Crit Care Nurs Clin North Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/14017430601054076","article-title":"Prevention of atrial fibrillation after cardiac surgery","volume":"41","author":"Tapio H","year":"2007","unstructured":"Tapio H, Jari H, Kimmo M, Juha H. Prevention of atrial fibrillation after cardiac surgery. Scand Cardiovasc J. 2007, 41:72-8. 10.1080\/14017430601054076","journal-title":"Scand Cardiovasc J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0034-7094(12)70110-1","article-title":"Dexmedetomidine: current role in anesthesia and intensive care","volume":"62","author":"Afonso J","year":"2012","unstructured":"Afonso J, Reis F. Dexmedetomidine: current role in anesthesia and intensive care. Rev Bras Anestesiol. 2012, 62:118-33. 10.1016\/S0034-7094(12)70110-1","journal-title":"Rev Bras Anestesiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4097\/kja.19259","article-title":"Dexmedetomidine: present and future directions","volume":"72","author":"Lee S","year":"2019","unstructured":"Lee S. Dexmedetomidine: present and future directions. Korean J Anesthesiol. 2019, 72:323-30. 10.4097\/kja.19259","journal-title":"Korean J Anesthesiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193303","article-title":"Does dexmedetomidine have an antiarrhythmic effect on cardiac patients? A meta-analysis of randomized controlled trials","volume":"13","author":"Ling X","year":"2018","unstructured":"Ling X, Zhou H, Ni Y, Wu C, Zhang C, Zhu Z. Does dexmedetomidine have an antiarrhythmic effect on cardiac patients? A meta-analysis of randomized controlled trials. PLoS One. 2018, 13:e0193303. 10.1371\/journal.pone.0193303","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/0971-9784.159801","article-title":"Effect of dexmeditomidine on postoperative junctional ectopic tachycardia after complete surgical repair of tetralogy of Fallot: a prospective randomized controlled study","volume":"18","author":"Kadam SV","year":"2015","unstructured":"Kadam SV, Tailor KB, Kulkarni S, Mohanty SR, Joshi PV, Rao SG. Effect of dexmeditomidine on postoperative junctional ectopic tachycardia after complete surgical repair of tetralogy of Fallot: a prospective randomized controlled study. Ann Card Anaesth. 2015, 18:323-8. 10.4103\/0971-9784.159801","journal-title":"Ann Card Anaesth"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2014.05.009","article-title":"Dexmedetomidine sedation after cardiac surgery decreases atrial arrhythmias","volume":"26","author":"Turan A","year":"2014","unstructured":"Turan A, Bashour CA, You J, Kirkova Y, Kurz A, Sessler DI, Saager L. Dexmedetomidine sedation after cardiac surgery decreases atrial arrhythmias. J Clin Anesth. 2014, 26:634-42. 10.1016\/j.jclinane.2014.05.009","journal-title":"J Clin Anesth"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.19-132","article-title":"Anxiety administrated by dexmedetomidine to prevent new-onset of postoperative atrial fibrillation in patients undergoing off-pump coronary artery bypass graft","volume":"61","author":"Zi J","year":"2020","unstructured":"Zi J, Fan Y, Dong C, Zhao Y, Li D, Tan Q. Anxiety administrated by dexmedetomidine to prevent new-onset of postoperative atrial fibrillation in patients undergoing off-pump coronary artery bypass graft. Int Heart J. 2020, 61:263-72. 10.1536\/ihj.19-132","journal-title":"Int Heart J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02175-2","article-title":"Nocturnal dexmedetomidine alleviates post-intensive care syndrome following cardiac surgery: a prospective randomized controlled clinical trial","volume":"19","author":"Dong CH","year":"2021","unstructured":"Dong CH, Gao CN, An XH, Li N, Yang L, Li DC, Tan Q. Nocturnal dexmedetomidine alleviates post-intensive care syndrome following cardiac surgery: a prospective randomized controlled clinical trial. BMC Med. 2021, 19:306. 10.1186\/s12916-021-02175-2","journal-title":"BMC Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1480-5","article-title":"Dexmedetomidine sedation reduces atrial fibrillation after cardiac surgery compared to propofol: a randomized controlled trial","volume":"20","author":"Liu X","year":"2016","unstructured":"Liu X, Zhang K, Wang W, Xie G, Fang X. Dexmedetomidine sedation reduces atrial fibrillation after cardiac surgery compared to propofol: a randomized controlled trial. Crit Care. 2016, 20:298. 10.1186\/s13054-016-1480-5","journal-title":"Crit Care"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-015-0092-5","article-title":"Dexmedetomidine sedation during the nighttime reduced the incidence of postoperative atrial fibrillation in cardiovascular surgery patients after tracheal extubation","volume":"3","author":"Narisawa A","year":"2015","unstructured":"Narisawa A, Nakane M, Kano T, et al.. Dexmedetomidine sedation during the nighttime reduced the incidence of postoperative atrial fibrillation in cardiovascular surgery patients after tracheal extubation. J Intensive Care. 2015, 3:26. 10.1186\/s40560-015-0092-5","journal-title":"J Intensive Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/anae.15947","article-title":"Dexmedetomidine for adult cardiac surgery: a systematic review, meta-analysis and trial sequential analysis","volume":"78","author":"Poon WH","year":"2023","unstructured":"Poon WH, Ling RR, Yang IX, et al.. Dexmedetomidine for adult cardiac surgery: a systematic review, meta-analysis and trial sequential analysis. Anaesthesia. 2023, 78:371-80. 10.1111\/anae.15947","journal-title":"Anaesthesia"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000001196","article-title":"Effect of dexmedetomidine on tachyarrhythmias after cardiac surgery: a systematic review and meta-analysis","volume":"79","author":"Wang W","year":"2022","unstructured":"Wang W, Liu J, Ye H, Wang M, Wang T. Effect of dexmedetomidine on tachyarrhythmias after cardiac surgery: a systematic review and meta-analysis. J Cardiovasc Pharmacol. 2022, 79:315-24. 10.1097\/FJC.0000000000001196","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.721264","article-title":"Influence of dexmedetomidine on post-operative atrial fibrillation after cardiac surgery: a meta-analysis of randomized controlled trials","volume":"8","author":"Peng S","year":"2021","unstructured":"Peng S, Wang J, Yu H, Cao G, Liu P. Influence of dexmedetomidine on post-operative atrial fibrillation after cardiac surgery: a meta-analysis of randomized controlled trials. Front Cardiovasc Med. 2021, 8:721264. 10.3389\/fcvm.2021.721264","journal-title":"Front Cardiovasc Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-019-00380-2","article-title":"Dexmedetomidine reduces atrial fibrillation after adult cardiac surgery: a meta-analysis of randomized controlled trials","volume":"20","author":"Liu Y","year":"2020","unstructured":"Liu Y, Zhang L, Wang S, Lu F, Zhen J, Chen W. Dexmedetomidine reduces atrial fibrillation after adult cardiac surgery: a meta-analysis of randomized controlled trials. Am J Cardiovasc Drugs. 2020, 20:271-81. 10.1007\/s40256-019-00380-2","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199511000-00013","article-title":"Role of the vagus nerve in the antidysrhythmic effect of dexmedetomidine on halothane\/epinephrine dysrhythmias in dogs","volume":"83","author":"Kamibayashi T","year":"1995","unstructured":"Kamibayashi T, Hayashi Y, Mammoto T, Yamatodani A, Sumikawa K, Yoshiya I. Role of the vagus nerve in the antidysrhythmic effect of dexmedetomidine on halothane\/epinephrine dysrhythmias in dogs. Anesthesiology. 1995, 83:992-9. 10.1097\/00000542-199511000-00013","journal-title":"Anesthesiology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-013-0659-7","article-title":"Dexmedetomidine: antiarrhythmic effects in the pediatric cardiac patient","volume":"34","author":"Tobias JD","year":"2013","unstructured":"Tobias JD, Chrysostomou C. Dexmedetomidine: antiarrhythmic effects in the pediatric cardiac patient. Pediatr Cardiol. 2013, 34:779-85. 10.1007\/s00246-013-0659-7","journal-title":"Pediatr Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-12-0171","article-title":"Dexmedetomidine and clonidine inhibit ventricular tachyarrhythmias in a rabbit model of acquired long QT syndrome","volume":"76","author":"Tsutsui K","year":"2012","unstructured":"Tsutsui K, Hayami N, Kunishima T, et al.. Dexmedetomidine and clonidine inhibit ventricular tachyarrhythmias in a rabbit model of acquired long QT syndrome. Circ J. 2012, 76:2343-7. 10.1253\/circj.cj-12-0171","journal-title":"Circ J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199107000-00018","article-title":"Dexmedetomidine prevents epinephrine-induced arrhythmias through stimulation of central alpha 2 adrenoceptors in halothane-anesthetized dogs","volume":"75","author":"Hayashi Y","year":"1991","unstructured":"Hayashi Y, Sumikawa K, Maze M, Yamatodani A, Kamibayashi T, Kuro M, Yoshiya I. Dexmedetomidine prevents epinephrine-induced arrhythmias through stimulation of central alpha 2 adrenoceptors in halothane-anesthetized dogs. Anesthesiology. 1991, 75:113-7. 10.1097\/00000542-199107000-00018","journal-title":"Anesthesiology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1213\/01.ane.0000217204.92904.76","article-title":"The use of dexmedetomidine in pediatric cardiac surgery","volume":"103","author":"Mukhtar AM","year":"2006","unstructured":"Mukhtar AM, Obayah EM, Hassona AM. The use of dexmedetomidine in pediatric cardiac surgery. Anesth Analg. 2006, 103:52-6, table of contents. 10.1213\/01.ane.0000217204.92904.76","journal-title":"Anesth Analg"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200611000-00010","article-title":"Effects of low and high plasma concentrations of dexmedetomidine on myocardial perfusion and cardiac function in healthy male subjects","volume":"105","author":"Snapir A","year":"2006","unstructured":"Snapir A, Posti J, Kentala E, et al.. Effects of low and high plasma concentrations of dexmedetomidine on myocardial perfusion and cardiac function in healthy male subjects. Anesthesiology. 2006, 105:902-10; quiz 1069-70. 10.1097\/00000542-200611000-00010","journal-title":"Anesthesiology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1213\/01.ane.0000297421.92857.4e","article-title":"The effects of dexmedetomidine on cardiac electrophysiology in children","volume":"106","author":"Hammer GB","year":"2008","unstructured":"Hammer GB, Drover DR, Cao H, et al.. The effects of dexmedetomidine on cardiac electrophysiology in children. Anesth Analg. 2008, 106:79-83, table of contents. 10.1213\/01.ane.0000297421.92857.4e","journal-title":"Anesth Analg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000000434","article-title":"Dexmedetomidine depresses sinoatrial and atrioventricular nodal function without any change in atrial fibrillation inducibility","volume":"68","author":"Sairaku A","year":"2016","unstructured":"Sairaku A, Nakano Y, Suenari K, et al.. Dexmedetomidine depresses sinoatrial and atrioventricular nodal function without any change in atrial fibrillation inducibility. J Cardiovasc Pharmacol. 2016, 68:473-8. 10.1097\/FJC.0000000000000434","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2009.01.031","article-title":"Postoperative inflammatory reaction and atrial fibrillation: simple correlation or causation?","volume":"88","author":"Anselmi A","year":"2009","unstructured":"Anselmi A, Possati G, Gaudino M. Postoperative inflammatory reaction and atrial fibrillation: simple correlation or causation?. Ann Thorac Surg. 2009, 88:326-33. 10.1016\/j.athoracsur.2009.01.031","journal-title":"Ann Thorac Surg"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00033","article-title":"Dexmedetomidine exerted anti-arrhythmic effects in rat with ischemic cardiomyopathy via upregulation of connexin 43 and reduction of fibrosis and inflammation","volume":"11","author":"Wu SJ","year":"2020","unstructured":"Wu SJ, Lin ZH, Lin YZ, Rao ZH, Lin JF, Wu LP, Li L. Dexmedetomidine exerted anti-arrhythmic effects in rat with ischemic cardiomyopathy via upregulation of connexin 43 and reduction of fibrosis and inflammation. Front Physiol. 2020, 11:33. 10.3389\/fphys.2020.00033","journal-title":"Front Physiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30631-0","article-title":"Dexmedetomidine for reduction of atrial fibrillation and delirium after cardiac surgery (DECADE): a randomised placebo-controlled trial","volume":"396","author":"Turan A","year":"2020","unstructured":"Turan A, Duncan A, Leung S, et al.. Dexmedetomidine for reduction of atrial fibrillation and delirium after cardiac surgery (DECADE): a randomised placebo-controlled trial. Lancet. 2020, 396:177-85. 10.1016\/S0140-6736(20)30631-0","journal-title":"Lancet"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06710-w","article-title":"Effects of dexmedetomidine on surgery for type A acute aortic dissection outcome","volume":"12","author":"Cheng YT","year":"2022","unstructured":"Cheng YT, Lee KT, Chang CH, et al.. Effects of dexmedetomidine on surgery for type A acute aortic dissection outcome. Sci Rep. 2022, 12:2761. 10.1038\/s41598-022-06710-w","journal-title":"Sci Rep"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1186\/cc11646","article-title":"Can dexmedetomidine be a safe and efficacious sedative agent in post-cardiac surgery patients? A meta-analysis","volume":"16","author":"Lin YY","year":"2012","unstructured":"Lin YY, He B, Chen J, Wang ZN. Can dexmedetomidine be a safe and efficacious sedative agent in post-cardiac surgery patients? A meta-analysis. Crit Care. 2012, 16:R169. 10.1186\/cc11646","journal-title":"Crit Care"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S153834","article-title":"Can dexmedetomidine reduce atrial fibrillation after cardiac surgery? A systematic review and meta-analysis","volume":"12","author":"Zhu Z","year":"2018","unstructured":"Zhu Z, Zhou H, Ni Y, Wu C, Zhang C, Ling X. Can dexmedetomidine reduce atrial fibrillation after cardiac surgery? A systematic review and meta-analysis. Drug Des Devel Ther. 2018, 12:521-31. 10.2147\/DDDT.S153834","journal-title":"Drug Des Devel Ther"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.4227","article-title":"Myocardial protective effects of dexmedetomidine in patients undergoing cardiac surgery: a meta-analysis and systematic review","volume":"13","author":"Gong Z","year":"2017","unstructured":"Gong Z, Ma L, Zhong YL, Li J, Lv J, Xie YB. Myocardial protective effects of dexmedetomidine in patients undergoing cardiac surgery: a meta-analysis and systematic review. Exp Ther Med. 2017, 13:2355-61. 10.3892\/etm.2017.4227","journal-title":"Exp Ther Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0202620","article-title":"The efficacy and safety of dexmedetomidine in cardiac surgery patients: a systematic review and meta-analysis","volume":"13","author":"Wang G","year":"2018","unstructured":"Wang G, Niu J, Li Z, Lv H, Cai H. The efficacy and safety of dexmedetomidine in cardiac surgery patients: a systematic review and meta-analysis. PLoS One. 2018, 13:e0202620. 10.1371\/journal.pone.0202620","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-013-1676-7","article-title":"Dexmedetomidine-induced atrioventricular block followed by cardiac arrest during atrial pacing: a case report and review of the literature","volume":"28","author":"Takata K","year":"2014","unstructured":"Takata K, Adachi YU, Suzuki K, Obata Y, Sato S, Nishiwaki K. Dexmedetomidine-induced atrioventricular block followed by cardiac arrest during atrial pacing: a case report and review of the literature. J Anesth. 2014, 28:116-20. 10.1007\/s00540-013-1676-7","journal-title":"J Anesth"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1097\/HPC.0b013e3181f4ec4a","article-title":"Evaluation of dexmedetomidine versus propofol-based sedation therapy in mechanically ventilated cardiac surgery patients at a tertiary academic medical center","volume":"9","author":"Anger KE","year":"2010","unstructured":"Anger KE, Szumita PM, Baroletti SA, Labreche MJ, Fanikos J. Evaluation of dexmedetomidine versus propofol-based sedation therapy in mechanically ventilated cardiac surgery patients at a tertiary academic medical center. Crit Pathw Cardiol. 2010, 9:221-6. 10.1097\/HPC.0b013e3181f4ec4a","journal-title":"Crit Pathw Cardiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4814037","article-title":"Comparison of dexmedetomidine, lidocaine, and fentanyl in attenuation hemodynamic response of laryngoscopy and intubation in patients undergoing cardiac surgery","volume":"2020","author":"Mahjoubifard M","year":"2020","unstructured":"Mahjoubifard M, Heidari M, Dahmardeh M, Mirtajani SB, Jahangirifard A. Comparison of dexmedetomidine, lidocaine, and fentanyl in attenuation hemodynamic response of laryngoscopy and intubation in patients undergoing cardiac surgery. Anesthesiol Res Pract. 2020, 2020:4814037. 10.1155\/2020\/4814037","journal-title":"Anesthesiol Res Pract"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-011-1215-3","article-title":"Dexmedetomidine can stabilize hemodynamics and spare anesthetics before cardiopulmonary bypass","volume":"25","author":"Kunisawa T","year":"2011","unstructured":"Kunisawa T, Ueno M, Kurosawa A, et al.. Dexmedetomidine can stabilize hemodynamics and spare anesthetics before cardiopulmonary bypass. J Anesth. 2011, 25:818-22. 10.1007\/s00540-011-1215-3","journal-title":"J Anesth"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.2006.01136.x","article-title":"The effects of pre-operative dexmedetomidine infusion on hemodynamics in patients with pulmonary hypertension undergoing mitral valve replacement surgery","volume":"50","author":"But AK","year":"2006","unstructured":"But AK, Ozgul U, Erdil F, Gulhas N, Toprak HI, Durmus M, Ersoy MO. The effects of pre-operative dexmedetomidine infusion on hemodynamics in patients with pulmonary hypertension undergoing mitral valve replacement surgery. Acta Anaesthesiol Scand. 2006, 50:1207-12. 10.1111\/j.1399-6576.2006.01136.x","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0b013e3181ceae7d","article-title":"Effect of dexmedetomidine on pulmonary artery pressure after congenital cardiac surgery: a pilot study","volume":"11","author":"Lazol JP","year":"2010","unstructured":"Lazol JP, Lichtenstein SE, Jooste EH, et al.. Effect of dexmedetomidine on pulmonary artery pressure after congenital cardiac surgery: a pilot study. Pediatr Crit Care Med. 2010, 11:589-92. 10.1097\/PCC.0b013e3181ceae7d","journal-title":"Pediatr Crit Care Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.4103\/aca.ACA_76_16","article-title":"Impact of dexmedetomidine on hemodynamic changes during and after coronary artery bypass grafting","volume":"20","author":"Hashemian M","year":"2017","unstructured":"Hashemian M, Ahmadinejad M, Mohajerani SA, Mirkheshti A. Impact of dexmedetomidine on hemodynamic changes during and after coronary artery bypass grafting. Ann Card Anaesth. 2017, 20:152-7. 10.4103\/aca.ACA_76_16","journal-title":"Ann Card Anaesth"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2016.05.038","article-title":"Dexmedetomidine versus propofol sedation improves sublingual microcirculation after cardiac surgery: a randomized controlled trial","volume":"30","author":"Liu X","year":"2016","unstructured":"Liu X, Zhang K, Wang W, et al.. Dexmedetomidine versus propofol sedation improves sublingual microcirculation after cardiac surgery: a randomized controlled trial. J Cardiothorac Vasc Anesth. 2016, 30:1509-15. 10.1053\/j.jvca.2016.05.038","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.23736\/S0375-9393.22.16782-9","article-title":"Dexmedetomidine versus remifentanil for sedation under monitored anesthetic care in complex endovascular aortic aneurysm repair: a single center experience with mid-term follow-up","volume":"89","author":"Monaco F","year":"2023","unstructured":"Monaco F, Barucco G, Lerose CC, et al.. Dexmedetomidine versus remifentanil for sedation under monitored anesthetic care in complex endovascular aortic aneurysm repair: a single center experience with mid-term follow-up. Minerva Anestesiol. 2023, 89:256-64. 10.23736\/S0375-9393.22.16782-9","journal-title":"Minerva Anestesiol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.12659\/msm.903501","article-title":"Bidirectional regulatory effects of dexmedetomidine on porcine coronary tone in vitro","volume":"23","author":"Zhou SZ","year":"2017","unstructured":"Zhou SZ, Li ZM, Liu XR, Zhou J, Tan XQ, Yang Y, Wei JC. Bidirectional regulatory effects of dexmedetomidine on porcine coronary tone in vitro. Med Sci Monit. 2017, 23:1621-6. 10.12659\/msm.903501","journal-title":"Med Sci Monit"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2019.10774","article-title":"Dexmedetomidine improves cardiac function and protects against maladaptive remodeling following myocardial infarction","volume":"20","author":"Han H","year":"2019","unstructured":"Han H, Dai D, Hu J, Zhu J, Lu L, Tao G, Zhang R. Dexmedetomidine improves cardiac function and protects against maladaptive remodeling following myocardial infarction. Mol Med Rep. 2019, 20:5183-9. 10.3892\/mmr.2019.10774","journal-title":"Mol Med Rep"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1080\/13510002.2022.2158526","article-title":"Dexmedetomidine postconditioning attenuates myocardial ischemia\/reperfusion injury by activating the Nrf2\/Sirt3\/SOD2 signaling pathway in the rats","volume":"28","author":"Hu B","year":"2023","unstructured":"Hu B, Tian T, Li XT, et al.. Dexmedetomidine postconditioning attenuates myocardial ischemia\/reperfusion injury by activating the Nrf2\/Sirt3\/SOD2 signaling pathway in the rats. Redox Rep. 2023, 28:2158526. 10.1080\/13510002.2022.2158526","journal-title":"Redox Rep"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20221306","article-title":"Role of Keap1-Nrf2\/ARE signal transduction pathway in protection of dexmedetomidine preconditioning against myocardial ischemia\/reperfusion injury","volume":"42","author":"Li HX","year":"2022","unstructured":"Li HX, Wang TH, Wu LX, Xue FS, Zhang GH, Yan T. Role of Keap1-Nrf2\/ARE signal transduction pathway in protection of dexmedetomidine preconditioning against myocardial ischemia\/reperfusion injury. Biosci Rep. 2022, 42:BSR20221306. 10.1042\/BSR20221306","journal-title":"Biosci Rep"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.12711","article-title":"Dexmedetomidine preconditioning for myocardial protection in ischaemia-reperfusion injury in rats by downregulation of the high mobility group box 1-toll-like receptor 4-nuclear factor \u03baB signalling pathway","volume":"44","author":"Yang YF","year":"2017","unstructured":"Yang YF, Peng K, Liu H, Meng XW, Zhang JJ, Ji FH. Dexmedetomidine preconditioning for myocardial protection in ischaemia-reperfusion injury in rats by downregulation of the high mobility group box 1-toll-like receptor 4-nuclear factor \u03baB signalling pathway. Clin Exp Pharmacol Physiol. 2017, 44:353-61. 10.1111\/1440-1681.12711","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-021-02082-6","article-title":"Dexmedetomidine alleviates cardiomyocyte apoptosis and cardiac dysfunction may be associated with inhibition of RhoA\/ROCK pathway in mice with myocardial infarction","volume":"394","author":"Sun T","year":"2021","unstructured":"Sun T, Gong Q, Wu Y, Shen Z, Zhang Y, Ge S, Duan JS. Dexmedetomidine alleviates cardiomyocyte apoptosis and cardiac dysfunction may be associated with inhibition of RhoA\/ROCK pathway in mice with myocardial infarction. Naunyn Schmiedebergs Arch Pharmacol. 2021, 394:1569-77. 10.1007\/s00210-021-02082-6","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3071959","article-title":"Effects of dexmedetomidine postconditioning on myocardial ischemia\/reperfusion injury in diabetic rats: role of the PI3K\/Akt-dependent signaling pathway","volume":"2018","author":"Cheng X","year":"2018","unstructured":"Cheng X, Hu J, Wang Y, Ye H, Li X, Gao Q, Li Z. Effects of dexmedetomidine postconditioning on myocardial ischemia\/reperfusion injury in diabetic rats: role of the PI3K\/Akt-dependent signaling pathway. J Diabetes Res. 2018, 2018:3071959. 10.1155\/2018\/3071959","journal-title":"J Diabetes Res"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-023-01388-7","article-title":"hUC-MSC-EV-miR-24 enhances the protective effect of dexmedetomidine preconditioning against myocardial ischemia-reperfusion injury through the KEAP1\/Nrf2\/HO-1 signaling","volume":"14","author":"Hou Z","year":"2024","unstructured":"Hou Z, Yang F, Chen K, Wang Y, Qin J, Liang F. hUC-MSC-EV-miR-24 enhances the protective effect of dexmedetomidine preconditioning against myocardial ischemia-reperfusion injury through the KEAP1\/Nrf2\/HO-1 signaling. Drug Deliv Transl Res. 2024, 14:143-57. 10.1007\/s13346-023-01388-7","journal-title":"Drug Deliv Transl Res"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-021-04102-8","article-title":"Dexmedetomidine reversed hypoxia\/reoxygenation injury-induced oxidative stress and endoplasmic reticulum stress-dependent apoptosis of cardiomyocytes via SIRT1\/CHOP signaling pathway","volume":"476","author":"Zhang Y","year":"2021","unstructured":"Zhang Y, Zhao Q, Li X, Ji F. Dexmedetomidine reversed hypoxia\/reoxygenation injury-induced oxidative stress and endoplasmic reticulum stress-dependent apoptosis of cardiomyocytes via SIRT1\/CHOP signaling pathway. Mol Cell Biochem. 2021, 476:2803-12. 10.1007\/s11010-021-04102-8","journal-title":"Mol Cell Biochem"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.18388\/abp.2020_5473","article-title":"Involvement of GPR30 in protection effect of dexmedetomidine against myocardial ischemia\/reperfusion injury in rat via AKT pathway","volume":"68","author":"Shao Z","year":"2021","unstructured":"Shao Z, Shen Q, Kong M, Ni H, Hou X. Involvement of GPR30 in protection effect of dexmedetomidine against myocardial ischemia\/reperfusion injury in rat via AKT pathway. Acta Biochim Pol. 2021, 68:119-26. 10.18388\/abp.2020_5473","journal-title":"Acta Biochim Pol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8979270","article-title":"Dexmedetomidine protects against myocardial ischemia\/reperfusion injury by ameliorating oxidative stress and cell apoptosis through the Trx1-dependent Akt pathway","volume":"2020","author":"Wu ZL","year":"2020","unstructured":"Wu ZL, Davis JR, Zhu Y. Dexmedetomidine protects against myocardial ischemia\/reperfusion injury by ameliorating oxidative stress and cell apoptosis through the Trx1-dependent Akt pathway. Biomed Res Int. 2020, 2020:8979270. 10.1155\/2020\/8979270","journal-title":"Biomed Res Int"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201908_18565","article-title":"Effects of dexmedetomidine on myocardial ischemia-reperfusion injury through PI3K-Akt-mTOR signaling pathway","volume":"23","author":"Zhang J","year":"2019","unstructured":"Zhang J, Jiang H, Liu DH, Wang GN. Effects of dexmedetomidine on myocardial ischemia-reperfusion injury through PI3K-Akt-mTOR signaling pathway. Eur Rev Med Pharmacol Sci. 2019, 23:6736-43. 10.26355\/eurrev_201908_18565","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.12791","article-title":"Dexmedetomidine protects mice against myocardium ischaemic\/reperfusion injury by activating an AMPK\/PI3K\/Akt\/eNOS pathway","volume":"44","author":"Sun Y","year":"2017","unstructured":"Sun Y, Jiang C, Jiang J, Qiu L. Dexmedetomidine protects mice against myocardium ischaemic\/reperfusion injury by activating an AMPK\/PI3K\/Akt\/eNOS pathway. Clin Exp Pharmacol Physiol. 2017, 44:946-53. 10.1111\/1440-1681.12791","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.repc.2020.07.019","article-title":"Dexmedetomidine attenuates H(2)O(2)-induced apoptosis of rat cardiomyocytes independently of antioxidant enzyme expression","volume":"40","author":"Weng X","year":"2021","unstructured":"Weng X, Shi W, Zhang X, Du J. Dexmedetomidine attenuates H(2)O(2)-induced apoptosis of rat cardiomyocytes independently of antioxidant enzyme expression. Rev Port Cardiol (Engl Ed). 2021, 40:273-81. 10.1016\/j.repc.2020.07.019","journal-title":"Rev Port Cardiol (Engl Ed)"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1177\/1470320314546941","article-title":"The efficacy and mechanism of dexmedetomidine in myocardial apoptosis via the renin-angiotensin-aldosterone system","volume":"16","author":"Wang H","year":"2015","unstructured":"Wang H, Zhang S, Xu S, Zhang L. The efficacy and mechanism of dexmedetomidine in myocardial apoptosis via the renin-angiotensin-aldosterone system. J Renin Angiotensin Aldosterone Syst. 2015, 16:1274-80. 10.1177\/1470320314546941","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1007\/s12265-021-10125-9","article-title":"The protective mechanism of dexmedetomidine in regulating Atg14L-Beclin1-Vps34 complex against myocardial ischemia-reperfusion injury","volume":"14","author":"Li Y","year":"2021","unstructured":"Li Y, Qu M, Xing F, Li H, Cheng D, Xing N, Zhang W. The protective mechanism of dexmedetomidine in regulating Atg14L-Beclin1-Vps34 complex against myocardial ischemia-reperfusion injury. J Cardiovasc Transl Res. 2021, 14:1063-74. 10.1007\/s12265-021-10125-9","journal-title":"J Cardiovasc Transl Res"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1111\/micc.12675","article-title":"Dexmedetomidine protects cardiac microvascular endothelial cells from the damage of ogd\/r through regulation of the ppar\u03b4-mediated autophagy","volume":"28","author":"Shao Q","year":"2021","unstructured":"Shao Q, Xia J, Wu P, Ying J. Dexmedetomidine protects cardiac microvascular endothelial cells from the damage of ogd\/r through regulation of the ppar\u03b4-mediated autophagy. Microcirculation. 2021, 28:e12675. 10.1111\/micc.12675","journal-title":"Microcirculation"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218726","article-title":"Dexmedetomidine-induced cardioprotection is mediated by inhibition of high mobility group box-1 and the cholinergic anti-inflammatory pathway in myocardial ischemia-reperfusion injury","volume":"14","author":"Zhang J","year":"2019","unstructured":"Zhang J, Xia F, Zhao H, et al.. Dexmedetomidine-induced cardioprotection is mediated by inhibition of high mobility group box-1 and the cholinergic anti-inflammatory pathway in myocardial ischemia-reperfusion injury. PLoS One. 2019, 14:e0218726. 10.1371\/journal.pone.0218726","journal-title":"PLoS One"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2022.2060900","article-title":"Dexmedetomidine promotes cell proliferation and inhibits cell apoptosis by regulating LINC00982 and activating the phosphoinositide-3-kinase (PI3K)\/protein kinase B (AKT) signaling in hypoxia\/reoxygenation-induced H9c2 cells","volume":"13","author":"Wang T","year":"2022","unstructured":"Wang T, Li Z, Xia S, Xu Z, Chen X, Sun H. Dexmedetomidine promotes cell proliferation and inhibits cell apoptosis by regulating LINC00982 and activating the phosphoinositide-3-kinase (PI3K)\/protein kinase B (AKT) signaling in hypoxia\/reoxygenation-induced H9c2 cells. Bioengineered. 2022, 13:10159-67. 10.1080\/21655979.2022.2060900","journal-title":"Bioengineered"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108894","article-title":"Involvement of miR-665 in protection effect of dexmedetomidine against oxidative stress injury in myocardial cells via CB2 and CK1","volume":"115","author":"Yu J","year":"2019","unstructured":"Yu J, Yang W, Wang W, et al.. Involvement of miR-665 in protection effect of dexmedetomidine against oxidative stress injury in myocardial cells via CB2 and CK1. Biomed Pharmacother. 2019, 115:108894. 10.1016\/j.biopha.2019.108894","journal-title":"Biomed Pharmacother"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109766","article-title":"Dexmedetomidine alleviates myocardial ischemia-reperfusion injury by down-regulating miR-34b-3p to activate the jagged1\/notch signaling pathway","volume":"116","author":"Guo P","year":"2023","unstructured":"Guo P, Yi H, Han M, Liu X, Chen K, Qing J, Yang F. Dexmedetomidine alleviates myocardial ischemia-reperfusion injury by down-regulating miR-34b-3p to activate the jagged1\/notch signaling pathway. Int Immunopharmacol. 2023, 116:109766. 10.1016\/j.intimp.2023.109766","journal-title":"Int Immunopharmacol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2023.101899","article-title":"Dexmedetomidine attenuates myocardial ischemia-reperfusion injury via inhibiting ferroptosis by the cAMP\/PKA\/CREB pathway","volume":"68","author":"Ma X","year":"2023","unstructured":"Ma X, Xu J, Gao N, Tian J, Song T. Dexmedetomidine attenuates myocardial ischemia-reperfusion injury via inhibiting ferroptosis by the cAMP\/PKA\/CREB pathway. Mol Cell Probes. 2023, 68:101899. 10.1016\/j.mcp.2023.101899","journal-title":"Mol Cell Probes"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106768","article-title":"Dexmedetomidine inhibits pyroptosis by down-regulating miR-29b in myocardial ischemia reperfusion injury in rats","volume":"86","author":"Zhong Y","year":"2020","unstructured":"Zhong Y, Li YP, Yin YQ, Hu BL, Gao H. Dexmedetomidine inhibits pyroptosis by down-regulating miR-29b in myocardial ischemia reperfusion injury in rats. Int Immunopharmacol. 2020, 86:106768. 10.1016\/j.intimp.2020.106768","journal-title":"Int Immunopharmacol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S265970","article-title":"Dexmedetomidine attenuates cellular injury and apoptosis in H9c2 cardiomyocytes by regulating p-38MAPK and endoplasmic reticulum stress","volume":"14","author":"Zhu Z","year":"2020","unstructured":"Zhu Z, Ling X, Zhou H, Zhang C, Yan W. Dexmedetomidine attenuates cellular injury and apoptosis in H9c2 cardiomyocytes by regulating p-38MAPK and endoplasmic reticulum stress. Drug Des Devel Ther. 2020, 14:4231-43. 10.2147\/DDDT.S265970","journal-title":"Drug Des Devel Ther"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.9564","article-title":"Dexmedetomidine at a dose of 1 \u00b5M attenuates H9c2 cardiomyocyte injury under 3 h of hypoxia exposure and 3 h of reoxygenation through the inhibition of endoplasmic reticulum stress","volume":"21","author":"Zhu Z","year":"2021","unstructured":"Zhu Z, Ling X, Zhou H, Zhang C. Dexmedetomidine at a dose of 1 \u00b5M attenuates H9c2 cardiomyocyte injury under 3 h of hypoxia exposure and 3 h of reoxygenation through the inhibition of endoplasmic reticulum stress. Exp Ther Med. 2021, 21:132. 10.3892\/etm.2020.9564","journal-title":"Exp Ther Med"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-016-0194-z","article-title":"Recent perioperative pharmacological prevention of acute kidney injury after cardiac surgery: a narrative review","volume":"17","author":"Li S","year":"2017","unstructured":"Li S, Fu S, Xiao Y, Xu G. Recent perioperative pharmacological prevention of acute kidney injury after cardiac surgery: a narrative review. Am J Cardiovasc Drugs. 2017, 17:17-25. 10.1007\/s40256-016-0194-z","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1097\/ACO.0000000000000213","article-title":"Novel therapy for renal protection","volume":"28","author":"Zarbock A","year":"2015","unstructured":"Zarbock A, Milles K. Novel therapy for renal protection. Curr Opin Anaesthesiol. 2015, 28:431-8. 10.1097\/ACO.0000000000000213","journal-title":"Curr Opin Anaesthesiol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2019.04.66","article-title":"Perioperative sedative use is not associated with acute kidney injury after total hip or knee arthroplasty","volume":"7","author":"Oh TK","year":"2019","unstructured":"Oh TK, Park JW, Shin HJ, Na HS, Oh AY, Hwang JW. Perioperative sedative use is not associated with acute kidney injury after total hip or knee arthroplasty. Ann Transl Med. 2019, 7:237. 10.21037\/atm.2019.04.66","journal-title":"Ann Transl Med"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2023.2192285","article-title":"Intraoperative dexmedetomidine use is associated with lower incidence of acute kidney injury after non-cardiac surgery","volume":"45","author":"Tang YZ","year":"2023","unstructured":"Tang YZ, Wang Q, Zhi L, et al.. Intraoperative dexmedetomidine use is associated with lower incidence of acute kidney injury after non-cardiac surgery. Ren Fail. 2023, 45:2192285. 10.1080\/0886022X.2023.2192285","journal-title":"Ren Fail"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1143176","article-title":"Correlation between perioperative dexmedetomidine administration and postoperative acute kidney injury in hypertensive patients undergoing non-cardiac surgery","volume":"14","author":"Li B","year":"2023","unstructured":"Li B, Chen M, Zeng Y, Luo S. Correlation between perioperative dexmedetomidine administration and postoperative acute kidney injury in hypertensive patients undergoing non-cardiac surgery. Front Pharmacol. 2023, 14:1143176. 10.3389\/fphar.2023.1143176","journal-title":"Front Pharmacol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.306","article-title":"Perioperative dexmedetomidine reduces the incidence and severity of acute kidney injury following valvular heart surgery","volume":"89","author":"Cho JS","year":"2016","unstructured":"Cho JS, Shim JK, Soh S, Kim MK, Kwak YL. Perioperative dexmedetomidine reduces the incidence and severity of acute kidney injury following valvular heart surgery. Kidney Int. 2016, 89:693-700. 10.1038\/ki.2015.306","journal-title":"Kidney Int"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2017.03.053","article-title":"The effect of dexmedetomidine on renal function in patients undergoing cardiac valve replacement under cardiopulmonary bypass: a double-blind randomized controlled trial","volume":"40","author":"Zhai M","year":"2017","unstructured":"Zhai M, Kang F, Han M, Huang X, Li J. The effect of dexmedetomidine on renal function in patients undergoing cardiac valve replacement under cardiopulmonary bypass: a double-blind randomized controlled trial. J Clin Anesth. 2017, 40:33-8. 10.1016\/j.jclinane.2017.03.053","journal-title":"J Clin Anesth"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2023.04.008","article-title":"Effect of dexmedetomidine on postoperative renal function in patients undergoing cardiac valve surgery under cardiopulmonary bypass: a randomized clinical trial","volume":"37","author":"Qiu YQ","year":"2023","unstructured":"Qiu YQ, Zhuang LP, Wu PY, et al.. Effect of dexmedetomidine on postoperative renal function in patients undergoing cardiac valve surgery under cardiopulmonary bypass: a randomized clinical trial. J Cardiothorac Vasc Anesth. 2023, 37:1424-32. 10.1053\/j.jvca.2023.04.008","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.938790","article-title":"Dexmedetomidine and acute kidney injury following cardiac surgery in pediatric patients-an updated systematic review and meta-analysis","volume":"9","author":"Wang H","year":"2022","unstructured":"Wang H, Zhang C, Li Y, Jia Y, Yuan S, Wang J, Yan F. Dexmedetomidine and acute kidney injury following cardiac surgery in pediatric patients-an updated systematic review and meta-analysis. Front Cardiovasc Med. 2022, 9:938790. 10.3389\/fcvm.2022.938790","journal-title":"Front Cardiovasc Med"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivu367","article-title":"The dose-related effects of dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study","volume":"20","author":"Balkanay OO","year":"2015","unstructured":"Balkanay OO, Goksedef D, Omeroglu SN, Ipek G. The dose-related effects of dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study. Interact Cardiovasc Thorac Surg. 2015, 20:209-14. 10.1093\/icvts\/ivu367","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077446","article-title":"Post-bypass dexmedetomidine use and postoperative acute kidney injury in patients undergoing cardiac surgery with cardiopulmonary bypass","volume":"8","author":"Ji F","year":"2013","unstructured":"Ji F, Li Z, Young JN, Yeranossian A, Liu H. Post-bypass dexmedetomidine use and postoperative acute kidney injury in patients undergoing cardiac surgery with cardiopulmonary bypass. PLoS One. 2013, 8:e77446. 10.1371\/journal.pone.0077446","journal-title":"PLoS One"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000000611","article-title":"Dexmedetomidine is associated with lower incidence of acute kidney injury after congenital heart surgery","volume":"17","author":"Kwiatkowski DM","year":"2016","unstructured":"Kwiatkowski DM, Axelrod DM, Sutherland SM, Tesoro TM, Krawczeski CD. Dexmedetomidine is associated with lower incidence of acute kidney injury after congenital heart surgery. Pediatr Crit Care Med. 2016, 17:128-34. 10.1097\/PCC.0000000000000611","journal-title":"Pediatr Crit Care Med"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjane.2023.07.003","article-title":"Does dexmedetomidine reduce the risk of acute kidney injury after cardiac surgery? A meta-analysis of randomized controlled trials","volume":"74","author":"Zhao C","year":"2024","unstructured":"Zhao C, Liu S, Zhang H, Gao M. Does dexmedetomidine reduce the risk of acute kidney injury after cardiac surgery? A meta-analysis of randomized controlled trials. Braz J Anesthesiol. 2024, 74:744446. 10.1016\/j.bjane.2023.07.003","journal-title":"Braz J Anesthesiol"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2019.09.011","article-title":"Effect of dexmedetomidine on cardiac surgery-associated acute kidney injury: a meta-analysis with trial sequential analysis of randomized controlled trials","volume":"34","author":"Peng K","year":"2020","unstructured":"Peng K, Li D, Applegate RL 2nd, Lubarsky DA, Ji FH, Liu H. Effect of dexmedetomidine on cardiac surgery-associated acute kidney injury: a meta-analysis with trial sequential analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2020, 34:603-13. 10.1053\/j.jvca.2019.09.011","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1186\/s12871-018-0472-1","article-title":"Dexmedetomidine prevents acute kidney injury after adult cardiac surgery: a meta-analysis of randomized controlled trials","volume":"18","author":"Liu Y","year":"2018","unstructured":"Liu Y, Sheng B, Wang S, Lu F, Zhen J, Chen W. Dexmedetomidine prevents acute kidney injury after adult cardiac surgery: a meta-analysis of randomized controlled trials. BMC Anesthesiol. 2018, 18:7. 10.1186\/s12871-018-0472-1","journal-title":"BMC Anesthesiol"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.3892\/br.2015.427","article-title":"Dexmedetomidine protects against acute kidney injury through downregulating inflammatory reactions in endotoxemia rats","volume":"3","author":"Tan F","year":"2015","unstructured":"Tan F, Chen Y, Yuan D, Gong C, Li X, Zhou S. Dexmedetomidine protects against acute kidney injury through downregulating inflammatory reactions in endotoxemia rats. Biomed Rep. 2015, 3:365-70. 10.3892\/br.2015.427","journal-title":"Biomed Rep"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007480","article-title":"The effect of intraoperative dexmedetomidine on acute kidney injury after pediatric congenital heart surgery: a prospective randomized trial","volume":"96","author":"Jo YY","year":"2017","unstructured":"Jo YY, Kim JY, Lee JY, Choi CH, Chang YJ, Kwak HJ. The effect of intraoperative dexmedetomidine on acute kidney injury after pediatric congenital heart surgery: a prospective randomized trial. Medicine (Baltimore). 2017, 96:e7480. 10.1097\/MD.0000000000007480","journal-title":"Medicine (Baltimore)"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1590\/s0034-70942005000400007","article-title":"Effects of dexmedetomidine on renal system and on vasopressin plasma levels. Experimental study in dogs","volume":"55","author":"Villela NR","year":"2005","unstructured":"Villela NR, do Nascimento J\u00fanior P, de Carvalho LR, Teixeira A. Effects of dexmedetomidine on renal system and on vasopressin plasma levels. Experimental study in dogs. Rev Bras Anestesiol. 2005, 55:429-40. 10.1590\/s0034-70942005000400007","journal-title":"Rev Bras Anestesiol"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5454210","article-title":"Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting p75NTR-mediated oxidative stress and apoptosis","volume":"2020","author":"Wang Z","year":"2020","unstructured":"Wang Z, Wu J, Hu Z, Luo C, Wang P, Zhang Y, Li H. Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting p75NTR-mediated oxidative stress and apoptosis. Oxid Med Cell Longev. 2020, 2020:5454210. 10.1155\/2020\/5454210","journal-title":"Oxid Med Cell Longev"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.109912","article-title":"Effects of dexmedetomidine on lipopolysaccharide-induced acute kidney injury in rats and mitochondrial function in cell culture","volume":"125","author":"Kiyonaga N","year":"2020","unstructured":"Kiyonaga N, Moriyama T, Kanmura Y. Effects of dexmedetomidine on lipopolysaccharide-induced acute kidney injury in rats and mitochondrial function in cell culture. Biomed Pharmacother. 2020, 125:109912. 10.1016\/j.biopha.2020.109912","journal-title":"Biomed Pharmacother"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3230490","article-title":"Dexmedetomidine preconditioning protects rats from renal ischemia-reperfusion injury accompanied with biphasic changes of nuclear factor-kappa B signaling","volume":"2020","author":"Bao N","year":"2020","unstructured":"Bao N, Tang B, Wang J. Dexmedetomidine preconditioning protects rats from renal ischemia-reperfusion injury accompanied with biphasic changes of nuclear factor-kappa B signaling. J Immunol Res. 2020, 2020:3230490. 10.1155\/2020\/3230490","journal-title":"J Immunol Res"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1186\/cc10283","article-title":"Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice","volume":"15","author":"Gu J","year":"2011","unstructured":"Gu J, Sun P, Zhao H, et al.. Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit Care. 2011, 15:R153. 10.1186\/cc10283","journal-title":"Crit Care"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118004","article-title":"Dexmedetomidine pretreatment attenuates myocardial ischemia reperfusion induced acute kidney injury and endoplasmic reticulum stress in human and rat","volume":"257","author":"Tang C","year":"2020","unstructured":"Tang C, Hu Y, Gao J, et al.. Dexmedetomidine pretreatment attenuates myocardial ischemia reperfusion induced acute kidney injury and endoplasmic reticulum stress in human and rat. Life Sci. 2020, 257:118004. 10.1016\/j.lfs.2020.118004","journal-title":"Life Sci"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00790","article-title":"Dexmedetomidine enhances autophagy via \u03b12-AR\/AMPK\/mTOR pathway to inhibit the activation of NLRP3 inflammasome and subsequently alleviates lipopolysaccharide-induced acute kidney injury","volume":"11","author":"Yang T","year":"2020","unstructured":"Yang T, Feng X, Zhao Y, et al.. Dexmedetomidine enhances autophagy via \u03b12-AR\/AMPK\/mTOR pathway to inhibit the activation of NLRP3 inflammasome and subsequently alleviates lipopolysaccharide-induced acute kidney injury. Front Pharmacol. 2020, 11:790. 10.3389\/fphar.2020.00790","journal-title":"Front Pharmacol"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-141","article-title":"Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK\/STAT signaling activation","volume":"11","author":"Si Y","year":"2013","unstructured":"Si Y, Bao H, Han L, et al.. Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK\/STAT signaling activation. J Transl Med. 2013, 11:141. 10.1186\/1479-5876-11-141","journal-title":"J Transl Med"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28539","article-title":"Dexmedetomidine ameliorates lipopolysaccharide-induced acute kidney injury in rats by inhibiting inflammation and oxidative stress via the GSK-3\u03b2\/Nrf2 signaling pathway","volume":"234","author":"Feng X","year":"2019","unstructured":"Feng X, Guan W, Zhao Y, et al.. Dexmedetomidine ameliorates lipopolysaccharide-induced acute kidney injury in rats by inhibiting inflammation and oxidative stress via the GSK-3\u03b2\/Nrf2 signaling pathway. J Cell Physiol. 2019, 234:18994-9009. 10.1002\/jcp.28539","journal-title":"J Cell Physiol"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.884907","article-title":"An update on postoperative cognitive dysfunction following cardiac surgery","volume":"13","author":"Vu T","year":"2022","unstructured":"Vu T, Smith JA. An update on postoperative cognitive dysfunction following cardiac surgery. Front Psychiatry. 2022, 13:884907. 10.3389\/fpsyt.2022.884907","journal-title":"Front Psychiatry"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2019.09.028","article-title":"Trials focusing on prevention and treatment of delirium after cardiac surgery: a systematic review of randomized evidence","volume":"34","author":"Pieri M","year":"2020","unstructured":"Pieri M, De Simone A, Rose S, et al.. Trials focusing on prevention and treatment of delirium after cardiac surgery: a systematic review of randomized evidence. J Cardiothorac Vasc Anesth. 2020, 34:1641-54. 10.1053\/j.jvca.2019.09.028","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1111\/anae.15469","article-title":"The effect of peri-operative dexmedetomidine on the incidence of postoperative delirium in cardiac and non-cardiac surgical patients: a randomised, double-blind placebo-controlled trial","volume":"76","author":"van Norden J","year":"2021","unstructured":"van Norden J, Spies CD, Borchers F, et al.. The effect of peri-operative dexmedetomidine on the incidence of postoperative delirium in cardiac and non-cardiac surgical patients: a randomised, double-blind placebo-controlled trial. Anaesthesia. 2021, 76:1342-51. 10.1111\/anae.15469","journal-title":"Anaesthesia"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000951","article-title":"Dexmedetomidine versus propofol sedation reduces delirium after cardiac surgery","volume":"124","author":"Djaiani G","year":"2016","unstructured":"Djaiani G, Silverton N, Fedorko L, Carroll J, Styra R, Rao V, Katznelson R. Dexmedetomidine versus propofol sedation reduces delirium after cardiac surgery. Anesthesiology. 2016, 124:362-8. 10.1097\/ALN.0000000000000951","journal-title":"Anesthesiology"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.01293","article-title":"Effect of ulinastatin combined with dexmedetomidine on postoperative cognitive dysfunction in patients who underwent cardiac surgery","volume":"10","author":"Zhou M","year":"2019","unstructured":"Zhou M, Lyu Y, Zhu Y, Jiang T, Wu C, Yang J, Wang L. Effect of ulinastatin combined with dexmedetomidine on postoperative cognitive dysfunction in patients who underwent cardiac surgery. Front Neurol. 2019, 10:1293. 10.3389\/fneur.2019.01293","journal-title":"Front Neurol"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2017.11.028","article-title":"Effects of dexmedetomidine-isoflurane versus isoflurane anesthesia on brain injury after cardiac valve replacement surgery","volume":"32","author":"Kang F","year":"2018","unstructured":"Kang F, Tang C, Han M, Chai X, Huang X, Li J. Effects of dexmedetomidine-isoflurane versus isoflurane anesthesia on brain injury after cardiac valve replacement surgery. J Cardiothorac Vasc Anesth. 2018, 32:1581-6. 10.1053\/j.jvca.2017.11.028","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1532\/hsf.4073","article-title":"Effect of dexmedetomidine on the neuroglobin expression in elderly patients with minimally invasive coronary artery bypass graft surgery","volume":"24","author":"Gao Y","year":"2021","unstructured":"Gao Y, Yu H, Wang W, Wang Y, Teng J, Li F. Effect of dexmedetomidine on the neuroglobin expression in elderly patients with minimally invasive coronary artery bypass graft surgery. Heart Surg Forum. 2021, 24:E776-80. 10.1532\/hsf.4073","journal-title":"Heart Surg Forum"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.5090\/kjtcs.2014.47.3.249","article-title":"Efficacy and safety of dexmedetomidine for postoperative delirium in adult cardiac surgery on cardiopulmonary bypass","volume":"47","author":"Park JB","year":"2014","unstructured":"Park JB, Bang SH, Chee HK, Kim JS, Lee SA, Shin JK. Efficacy and safety of dexmedetomidine for postoperative delirium in adult cardiac surgery on cardiopulmonary bypass. Korean J Thorac Cardiovasc Surg. 2014, 47:249-54. 10.5090\/kjtcs.2014.47.3.249","journal-title":"Korean J Thorac Cardiovasc Surg"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.0234","article-title":"Effect of intravenous acetaminophen vs placebo combined with propofol or dexmedetomidine on postoperative delirium among older patients following cardiac surgery the DEXACET randomized clinical trial","volume":"321","author":"Subramaniam B","year":"2019","unstructured":"Subramaniam B, Shankar P, Shaefi S, et al.. Effect of intravenous acetaminophen vs placebo combined with propofol or dexmedetomidine on postoperative delirium among older patients following cardiac surgery the DEXACET randomized clinical trial. JAMA. 2019, 321:686-96. 10.1001\/jama.2019.0234","journal-title":"JAMA"},{"key":"ref104","article-title":"Comparison between the effects of dexmedetomidine and midazolam on postoperative cognitive impairment after coronary artery bypasses graft surgery: a randomized clinical trial","volume":"14","author":"Rajaei M","year":"2019","unstructured":"Rajaei M, Tabari M, Soltani G, Alizadeh K, Nazari A, Noroozian M, Morovatdar N. Comparison between the effects of dexmedetomidine and midazolam on postoperative cognitive impairment after coronary artery bypasses graft surgery: a randomized clinical trial. J Tehran Heart Cent. 2019, 14:67-73.","journal-title":"J Tehran Heart Cent"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2020.02.035","article-title":"Perioperative dexmedetomidine supplement decreases delirium incidence after adult cardiac surgery: a randomized, double-blind, controlled study","volume":"35","author":"Likhvantsev VV","year":"2021","unstructured":"Likhvantsev VV, Landoni G, Grebenchikov OA, et al.. Perioperative dexmedetomidine supplement decreases delirium incidence after adult cardiac surgery: a randomized, double-blind, controlled study. J Cardiothorac Vasc Anesth. 2021, 35:449-57. 10.1053\/j.jvca.2020.02.035","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170757","article-title":"Impact of dexmedetomidine on the incidence of delirium in elderly patients after cardiac surgery: a randomized controlled trial","volume":"12","author":"Li X","year":"2017","unstructured":"Li X, Yang J, Nie XL, et al.. Impact of dexmedetomidine on the incidence of delirium in elderly patients after cardiac surgery: a randomized controlled trial. PLoS One. 2017, 12:e0170757. 10.1371\/journal.pone.0170757","journal-title":"PLoS One"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.5589","article-title":"An investigation of the mechanism of dexmedetomidine in improving postoperative cognitive dysfunction from the perspectives of alleviating neuronal mitochondrial membrane oxidative stress and electrophysiological dysfunction","volume":"15","author":"Chen J","year":"2018","unstructured":"Chen J, Shen N, Duan X, Guo Y. An investigation of the mechanism of dexmedetomidine in improving postoperative cognitive dysfunction from the perspectives of alleviating neuronal mitochondrial membrane oxidative stress and electrophysiological dysfunction. Exp Ther Med. 2018, 15:2037-43. 10.3892\/etm.2017.5589","journal-title":"Exp Ther Med"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2018.03.043","article-title":"Dexmedetomidine promotes the recovery of neurogenesis in aged mouse with postoperative cognitive dysfunction","volume":"677","author":"Wang WX","year":"2018","unstructured":"Wang WX, Wu Q, Liang SS, et al.. Dexmedetomidine promotes the recovery of neurogenesis in aged mouse with postoperative cognitive dysfunction. Neurosci Lett. 2018, 677:110-6. 10.1016\/j.neulet.2018.03.043","journal-title":"Neurosci Lett"},{"key":"ref109","article-title":"Dexmedetomidine alleviates postoperative cognitive dysfunction by inhibiting neuron excitation in aged rats","volume":"8","author":"Xiong B","year":"2016","unstructured":"Xiong B, Shi Q, Fang H. Dexmedetomidine alleviates postoperative cognitive dysfunction by inhibiting neuron excitation in aged rats. Am J Transl Res. 2016, 8:70-80.","journal-title":"Am J Transl Res"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-022-03706-w","article-title":"Dexmedetomidine ameliorated cognitive dysfunction induced by intestinal ischemia reperfusion in mice with possible relation to the anti-inflammatory effect through the locus coeruleus norepinephrine system","volume":"47","author":"Li G","year":"2022","unstructured":"Li G, Zhou J, Wei J, Liu B. Dexmedetomidine ameliorated cognitive dysfunction induced by intestinal ischemia reperfusion in mice with possible relation to the anti-inflammatory effect through the locus coeruleus norepinephrine system. Neurochem Res. 2022, 47:3440-53. 10.1007\/s11064-022-03706-w","journal-title":"Neurochem Res"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2016.04.074","article-title":"Attenuation of neuroinflammation by dexmedetomidine is associated with activation of a cholinergic anti-inflammatory pathway in a rat tibial fracture model","volume":"1644","author":"Zhu YJ","year":"2016","unstructured":"Zhu YJ, Peng K, Meng XW, Ji FH. Attenuation of neuroinflammation by dexmedetomidine is associated with activation of a cholinergic anti-inflammatory pathway in a rat tibial fracture model. Brain Res. 2016, 1644:1-8. 10.1016\/j.brainres.2016.04.074","journal-title":"Brain Res"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-021-02417-7","article-title":"Dexmedetomidine ameliorates postoperative cognitive dysfunction via the microRNA-381-mediated EGR1\/p53 axis","volume":"58","author":"Wang YL","year":"2021","unstructured":"Wang YL, Zhang Y, Cai DS. Dexmedetomidine ameliorates postoperative cognitive dysfunction via the microRNA-381-mediated EGR1\/p53 axis. Mol Neurobiol. 2021, 58:5052-66. 10.1007\/s12035-021-02417-7","journal-title":"Mol Neurobiol"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1353778","article-title":"Dexmedetomidine mitigates microglial activation associated with postoperative cognitive dysfunction by modulating the microRNA-103a-3p\/VAMP1 axis","volume":"2022","author":"Wu Z","year":"2022","unstructured":"Wu Z, Wang H, Shi Z, Li Y. Dexmedetomidine mitigates microglial activation associated with postoperative cognitive dysfunction by modulating the microRNA-103a-3p\/VAMP1 axis. Neural Plast. 2022, 2022:1353778. 10.1155\/2022\/1353778","journal-title":"Neural Plast"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2021.07.057","article-title":"Protective role of dexmedetomidine against sevoflurane-induced postoperative cognitive dysfunction via the microRNA-129\/TLR4 axis","volume":"92","author":"Wei W","year":"2021","unstructured":"Wei W, Sun Z, He S, Zhang W, Chen S. Protective role of dexmedetomidine against sevoflurane-induced postoperative cognitive dysfunction via the microRNA-129\/TLR4 axis. J Clin Neurosci. 2021, 92:89-97. 10.1016\/j.jocn.2021.07.057","journal-title":"J Clin Neurosci"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.3892\/br.2023.1682","article-title":"Dexmedetomidine attenuates the neuroinflammation and cognitive dysfunction in aged mice by targeting the SNHG14\/miR\u2011340\/NF\u2011\u03baB axis","volume":"19","author":"He G","year":"2023","unstructured":"He G, Ni H, Wang K, et al.. Dexmedetomidine attenuates the neuroinflammation and cognitive dysfunction in aged mice by targeting the SNHG14\/miR\u2011340\/NF\u2011\u03baB axis. Biomed Rep. 2023, 19:100. 10.3892\/br.2023.1682","journal-title":"Biomed Rep"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-022-06091-y","article-title":"Dexmedetomidine attenuates hippocampal neuroinflammation in postoperative neurocognitive disorders by inhibiting microRNA-329-3p and activating the CREB1\/IL1RA axis","volume":"239","author":"Chen J","year":"2022","unstructured":"Chen J, Ding Q, Jiao X, Wang B, Sun Z, Zhang Y, Zhao J. Dexmedetomidine attenuates hippocampal neuroinflammation in postoperative neurocognitive disorders by inhibiting microRNA-329-3p and activating the CREB1\/IL1RA axis. Psychopharmacology (Berl). 2022, 239:2171-86. 10.1007\/s00213-022-06091-y","journal-title":"Psychopharmacology (Berl)"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-020-2163-0","article-title":"Dexmedetomidine alleviates postoperative cognitive dysfunction through circular RNA in aged rats","volume":"10","author":"Cao C","year":"2020","unstructured":"Cao C, Deng F, Hu Y. Dexmedetomidine alleviates postoperative cognitive dysfunction through circular RNA in aged rats. 3 Biotech. 2020, 10:176. 10.1007\/s13205-020-2163-0","journal-title":"3 Biotech"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-020-02190-9","article-title":"Whole transcriptome sequencing reveals dexmedetomidine-improves postoperative cognitive dysfunction in rats via modulating lncRNA","volume":"10","author":"Deng F","year":"2020","unstructured":"Deng F, Cai L, Zhou B, Zhou Z, Xu G. Whole transcriptome sequencing reveals dexmedetomidine-improves postoperative cognitive dysfunction in rats via modulating lncRNA. 3 Biotech. 2020, 10:202. 10.1007\/s13205-020-02190-9","journal-title":"3 Biotech"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8830706","article-title":"Study on the effect of dexmedetomidine on postoperative cognitive dysfunction and inflammation in aged rats","volume":"2022","author":"Hou M","year":"2022","unstructured":"Hou M, Zhang Q, Deng K. Study on the effect of dexmedetomidine on postoperative cognitive dysfunction and inflammation in aged rats. Contrast Media Mol Imaging. 2022, 2022:8830706. 10.1155\/2022\/8830706","journal-title":"Contrast Media Mol Imaging"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2014.11.017","article-title":"Dexmedetomidine improves early postoperative cognitive dysfunction in aged mice","volume":"746","author":"Qian XL","year":"2015","unstructured":"Qian XL, Zhang W, Liu MZ, et al.. Dexmedetomidine improves early postoperative cognitive dysfunction in aged mice. Eur J Pharmacol. 2015, 746:206-12. 10.1016\/j.ejphar.2014.11.017","journal-title":"Eur J Pharmacol"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-021-03386-y","article-title":"Dexmedetomidine ameliorates postoperative cognitive dysfunction in aged mice","volume":"46","author":"Xie X","year":"2021","unstructured":"Xie X, Shen Z, Hu C, Zhang K, Guo M, Wang F, Qin K. Dexmedetomidine ameliorates postoperative cognitive dysfunction in aged mice. Neurochem Res. 2021, 46:2415-26. 10.1007\/s11064-021-03386-y","journal-title":"Neurochem Res"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.10470","article-title":"Dexmedetomidine facilitates the expression of nNOS in the hippocampus to alleviate surgery-induced neuroinflammation and cognitive dysfunction in aged rats","volume":"22","author":"Suo L","year":"2021","unstructured":"Suo L, Wang M. Dexmedetomidine facilitates the expression of nNOS in the hippocampus to alleviate surgery-induced neuroinflammation and cognitive dysfunction in aged rats. Exp Ther Med. 2021, 22:1038. 10.3892\/etm.2021.10470","journal-title":"Exp Ther Med"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113006","article-title":"Dexmedetomidine attenuates perioperative neurocognitive disorders by suppressing hippocampal neuroinflammation and HMGB1\/RAGE\/NF-\u03baB signaling pathway","volume":"150","author":"Wang J","year":"2022","unstructured":"Wang J, Xin Y, Chu T, Liu C, Xu A. Dexmedetomidine attenuates perioperative neurocognitive disorders by suppressing hippocampal neuroinflammation and HMGB1\/RAGE\/NF-\u03baB signaling pathway. Biomed Pharmacother. 2022, 150:113006. 10.1016\/j.biopha.2022.113006","journal-title":"Biomed Pharmacother"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.646265","article-title":"Dexmedetomidine mitigated NLRP3-mediated neuroinflammation via the ubiquitin-autophagy pathway to improve perioperative neurocognitive disorder in mice","volume":"12","author":"Zhang L","year":"2021","unstructured":"Zhang L, Xiao F, Zhang J, et al.. Dexmedetomidine mitigated NLRP3-mediated neuroinflammation via the ubiquitin-autophagy pathway to improve perioperative neurocognitive disorder in mice. Front Pharmacol. 2021, 12:646265. 10.3389\/fphar.2021.646265","journal-title":"Front Pharmacol"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158806","article-title":"Neuroprotective effect of dexmedetomidine against postoperative cognitive decline via NLRP3 inflammasome signaling pathway","volume":"23","author":"Cho I","year":"2022","unstructured":"Cho I, Koo BN, Kim SY, Park S, Kim EJ, Kam EH, Kim J. Neuroprotective effect of dexmedetomidine against postoperative cognitive decline via NLRP3 inflammasome signaling pathway. Int J Mol Sci. 2022, 23:8806. 10.3390\/ijms23158806","journal-title":"Int J Mol Sci"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000005268","article-title":"Dexmedetomidine and clonidine attenuate sevoflurane-induced tau phosphorylation and cognitive impairment in young mice via \u03b1-2 adrenergic receptor","volume":"132","author":"Sun M","year":"2021","unstructured":"Sun M, Dong Y, Li M, et al.. Dexmedetomidine and clonidine attenuate sevoflurane-induced tau phosphorylation and cognitive impairment in young mice via \u03b1-2 adrenergic receptor. Anesth Analg. 2021, 132:878-89. 10.1213\/ANE.0000000000005268","journal-title":"Anesth Analg"},{"key":"ref127","article-title":"Dexmedetomidine attenuates isoflurane-induced cognitive impairment through antioxidant, anti-inflammatory and anti-apoptosis in aging rat","volume":"8","author":"Wang X","year":"2015","unstructured":"Wang X, Zhao B, Li X. Dexmedetomidine attenuates isoflurane-induced cognitive impairment through antioxidant, anti-inflammatory and anti-apoptosis in aging rat. Int J Clin Exp Med. 2015, 8:17281-8.","journal-title":"Int J Clin Exp Med"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.1159\/000490823","article-title":"Dexmedetomidine protects neural stem cells from ketamine-induced injury","volume":"47","author":"Lu P","year":"2018","unstructured":"Lu P, Lei S, Li W, et al.. Dexmedetomidine protects neural stem cells from ketamine-induced injury. Cell Physiol Biochem. 2018, 47:1377-88. 10.1159\/000490823","journal-title":"Cell Physiol Biochem"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfz135","article-title":"Both GSK-3\u03b2\/CRMP2 and CDK5\/CRMP2 pathways participate in the protection of dexmedetomidine against propofol-induced learning and memory impairment in neonatal rats","volume":"171","author":"Li J","year":"2019","unstructured":"Li J, Guo M, Liu Y, et al.. Both GSK-3\u03b2\/CRMP2 and CDK5\/CRMP2 pathways participate in the protection of dexmedetomidine against propofol-induced learning and memory impairment in neonatal rats. Toxicol Sci. 2019, 171:193-210. 10.1093\/toxsci\/kfz135","journal-title":"Toxicol Sci"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.110114","article-title":"Dexmedetomidine suppresses the isoflurane-induced neurological damage by upregulating heme oxygenase-1 via activation of the mitogen-activated protein kinase kinase 1\/extracellular regulated protein kinases 1\/nuclear factor erythroid 2-related factor 2 axis in aged rats","volume":"367","author":"Huang H","year":"2022","unstructured":"Huang H, Zhu Y, Zhang Y, Hou B, Zhang Q, Shi X, Min J. Dexmedetomidine suppresses the isoflurane-induced neurological damage by upregulating heme oxygenase-1 via activation of the mitogen-activated protein kinase kinase 1\/extracellular regulated protein kinases 1\/nuclear factor erythroid 2-related factor 2 axis in aged rats. Chem Biol Interact. 2022, 367:110114. 10.1016\/j.cbi.2022.110114","journal-title":"Chem Biol Interact"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2022.2121921","article-title":"Dexmedetomidine alleviates sevoflurane-induced neuroinflammation and neurocognitive disorders by suppressing the P2X4R\/NLRP3 pathway in aged mice","volume":"134","author":"Li N","year":"2024","unstructured":"Li N, Ma Y, Li C, Sun M, Qi F. Dexmedetomidine alleviates sevoflurane-induced neuroinflammation and neurocognitive disorders by suppressing the P2X4R\/NLRP3 pathway in aged mice. Int J Neurosci. 2024, 134:511-21. 10.1080\/00207454.2022.2121921","journal-title":"Int J Neurosci"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-019-02081-1","article-title":"Molecular determinants of behavioral changes induced by neonatal ketamine and dexmedetomidine application","volume":"126","author":"Turktan M","year":"2019","unstructured":"Turktan M, Yilmaz MB, Hatipoglu Z, et al.. Molecular determinants of behavioral changes induced by neonatal ketamine and dexmedetomidine application. J Neural Transm (Vienna). 2019, 126:1577-88. 10.1007\/s00702-019-02081-1","journal-title":"J Neural Transm (Vienna)"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093639","article-title":"Dexmedetomidine reduces isoflurane-induced neuroapoptosis partly by preserving PI3K\/Akt pathway in the hippocampus of neonatal rats","volume":"9","author":"Li Y","year":"2014","unstructured":"Li Y, Zeng M, Chen W, et al.. Dexmedetomidine reduces isoflurane-induced neuroapoptosis partly by preserving PI3K\/Akt pathway in the hippocampus of neonatal rats. PLoS One. 2014, 9:e93639. 10.1371\/journal.pone.0093639","journal-title":"PLoS One"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2014.07.001","article-title":"Both JNK and P38 MAPK pathways participate in the protection by dexmedetomidine against isoflurane-induced neuroapoptosis in the hippocampus of neonatal rats","volume":"107","author":"Liao Z","year":"2014","unstructured":"Liao Z, Cao D, Han X, et al.. Both JNK and P38 MAPK pathways participate in the protection by dexmedetomidine against isoflurane-induced neuroapoptosis in the hippocampus of neonatal rats. Brain Res Bull. 2014, 107:69-78. 10.1016\/j.brainresbull.2014.07.001","journal-title":"Brain Res Bull"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000002217","article-title":"Dexmedetomidine ameliorates acute brain injury induced by myocardial ischemia-reperfusion via upregulating the HIF-1 pathway","volume":"60","author":"Yang X","year":"2023","unstructured":"Yang X, Wu J, Cheng H, Chen S, Wang J. Dexmedetomidine ameliorates acute brain injury induced by myocardial ischemia-reperfusion via upregulating the HIF-1 pathway. Shock. 2023, 60:678-87. 10.1097\/SHK.0000000000002217","journal-title":"Shock"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2021.03.040","article-title":"Perioperative dexmedetomidine and 5-year survival in patients undergoing cardiac surgery","volume":"127","author":"Peng K","year":"2021","unstructured":"Peng K, Shen YP, Ying YY, et al.. Perioperative dexmedetomidine and 5-year survival in patients undergoing cardiac surgery. Br J Anaesth. 2021, 127:215-23. 10.1016\/j.bja.2021.03.040","journal-title":"Br J Anaesth"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.000936","article-title":"Perioperative dexmedetomidine improves outcomes of cardiac surgery","volume":"127","author":"Ji F","year":"2013","unstructured":"Ji F, Li Z, Nguyen H, Young N, Shi P, Fleming N, Liu H. Perioperative dexmedetomidine improves outcomes of cardiac surgery. Circulation. 2013, 127:1576-84. 10.1161\/CIRCULATIONAHA.112.000936","journal-title":"Circulation"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2013.06.022","article-title":"Perioperative dexmedetomidine improves mortality in patients undergoing coronary artery bypass surgery","volume":"28","author":"Ji F","year":"2014","unstructured":"Ji F, Li Z, Young N, Moore P, Liu H. Perioperative dexmedetomidine improves mortality in patients undergoing coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 2014, 28:267-73. 10.1053\/j.jvca.2013.06.022","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2018.10.022","article-title":"Effects of perioperative dexmedetomidine on postoperative mortality and morbidity: a systematic review and meta-analysis","volume":"41","author":"Peng K","year":"2019","unstructured":"Peng K, Ji FH, Liu HY, Zhang J, Chen QC, Jiang YH. Effects of perioperative dexmedetomidine on postoperative mortality and morbidity: a systematic review and meta-analysis. Clin Ther. 2019, 41:138-154.e4. 10.1016\/j.clinthera.2018.10.022","journal-title":"Clin Ther"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002801","article-title":"Impact of dexmedetomidine on long-term outcomes after noncardiac surgery in elderly: 3-year follow-up of a randomized controlled trial","volume":"270","author":"Zhang DF","year":"2019","unstructured":"Zhang DF, Su X, Meng ZT, et al.. Impact of dexmedetomidine on long-term outcomes after noncardiac surgery in elderly: 3-year follow-up of a randomized controlled trial. Ann Surg. 2019, 270:356-63. 10.1097\/SLA.0000000000002801","journal-title":"Ann Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/366242-effect-of-perioperative-dexmedetomidine-in-cardiac-surgery-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T14:29:08Z","timestamp":1755872948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/366242-effect-of-perioperative-dexmedetomidine-in-cardiac-surgery-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":140,"URL":"https:\/\/doi.org\/10.7759\/cureus.90748","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,22]]}}}